273 related articles for article (PubMed ID: 28532573)
21. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A
Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151
[TBL] [Abstract][Full Text] [Related]
22. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.
Burmester GR; Ferraccioli G; Flipo RM; Monteagudo-Sáez I; Unnebrink K; Kary S; Kupper H
Arthritis Rheum; 2008 Jan; 59(1):32-41. PubMed ID: 18163417
[TBL] [Abstract][Full Text] [Related]
23. Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.
Rintelen B; Sautner J; Haindl P; Mai H; Brezinschek HP; Leeb BF
J Rheumatol; 2013 Apr; 40(4):394-400. PubMed ID: 23378466
[TBL] [Abstract][Full Text] [Related]
24. High patient global assessment scores in patients with rheumatoid arthritis otherwise in remission do not reflect subclinical inflammation.
Brites L; Rovisco J; Costa F; Freitas JPD; Jesus D; Eugénio G; Serra S; Duarte C; Ferreira RJO; da Silva JAPD
Joint Bone Spine; 2021 Dec; 88(6):105242. PubMed ID: 34166795
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
[TBL] [Abstract][Full Text] [Related]
26. A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.
Inderjeeth CA; Inderjeeth AJ; Raymond WD
Int J Rheum Dis; 2019 Jan; 22(1):73-80. PubMed ID: 30187688
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and safety of infliximab in rheumatoid arthritis: analysis from a Canadian multicenter prospective observational registry.
Thorne C; Bensen WG; Choquette D; Chow A; Khraishi M; Atkins CJ; Kelsall JT; Lehman AJ; Shawi M; Khalil H; Nantel F; Rampakakis E; Sampalis JS; Otawa S
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1142-51. PubMed ID: 24470077
[TBL] [Abstract][Full Text] [Related]
28. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
Lillegraven S; Prince FH; Shadick NA; Bykerk VP; Lu B; Frits ML; Iannaccone CK; Kvien TK; Haavardsholm EA; Weinblatt ME; Solomon DH
Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
[TBL] [Abstract][Full Text] [Related]
29. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
[TBL] [Abstract][Full Text] [Related]
30. Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity.
Hattori Y; Kida D; Kaneko A
Clin Rheumatol; 2017 Nov; 36(11):2607-2612. PubMed ID: 28823077
[TBL] [Abstract][Full Text] [Related]
31. Signs of forefeet joint synovitis have a limited impact on patient's perception of rheumatoid arthritis disease activity and acute-phase reactants.
Naniwa T; Iwagaitsu S; Tamechika S; Maeda S; Niimi A
Mod Rheumatol; 2016; 26(2):200-5. PubMed ID: 26166492
[TBL] [Abstract][Full Text] [Related]
32. Remission in early rheumatoid arthritis: predicting treatment response.
Ma MH; Ibrahim F; Walker D; Hassell A; Choy EH; Kiely PD; Williams R; Walsh DA; Young A; Scott DL
J Rheumatol; 2012 Mar; 39(3):470-5. PubMed ID: 22247360
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
de Punder YM; Fransen J; Kievit W; Houtman PM; Visser H; van de Laar MA; van Riel PL
Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487
[TBL] [Abstract][Full Text] [Related]
34. Discordance and accordance between patient's and physician's assessments in rheumatoid arthritis.
Furu M; Hashimoto M; Ito H; Fujii T; Terao C; Yamakawa N; Yoshitomi H; Ogino H; Ishikawa M; Matsuda S; Mimori T
Scand J Rheumatol; 2014; 43(4):291-5. PubMed ID: 24650255
[TBL] [Abstract][Full Text] [Related]
35. A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.
Bentley MJ; Greenberg JD; Reed GW
J Rheumatol; 2010 Aug; 37(8):1607-14. PubMed ID: 20595282
[TBL] [Abstract][Full Text] [Related]
36. Measures of arthritis activity associated with patient-reported improvement in rheumatoid arthritis when assessed prospectively versus retrospectively.
Ward MM; Guthrie LC; Alba MI
Arthritis Care Res (Hoboken); 2015 May; 67(6):776-81. PubMed ID: 25370806
[TBL] [Abstract][Full Text] [Related]
37. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
Haugeberg G; Hansen IJ; Soldal DM; Sokka T
Arthritis Res Ther; 2015 Aug; 17(1):219. PubMed ID: 26290061
[TBL] [Abstract][Full Text] [Related]
38. The new ACR/EULAR remission criteria: rationale for developing new criteria for remission.
Bykerk VP; Massarotti EM
Rheumatology (Oxford); 2012 Dec; 51 Suppl 6():vi16-20. PubMed ID: 23221582
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE;
Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230
[TBL] [Abstract][Full Text] [Related]
40. Determinants of Patient's Global Assessment of Disease Activity and Physician's Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials.
Kaneko Y; Takeuchi T; Cai Z; Sato M; Awakura K; Gaich C; Zhu B; Guo J; Tanaka Y
Mod Rheumatol; 2018 Nov; 28(6):960-967. PubMed ID: 29278339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
